Trial Profile
Phase IIb trial of leucine/metformin in patients with type 2 diabetes mellitus
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 15 Oct 2014
Price :
$35
*
At a glance
- Drugs Leucine/metformin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors NuSirt Biopharma
- 15 Oct 2014 New trial record
- 20 Aug 2014 This trial will be initiated if the phase IIa trial (see profile 245735) is successful, according to a NuSirt Biopharma media release.